A citation-based method for searching scientific literature

Gu Xiao, Devon Lundine, George K Annor, Jorge Canar, Viola Ellison, Alla Polotskaia, Patrick L Donabedian, Thomas Reiner, Galina F Khramtsova, Olufunmilayo I Olopade, Alexander Mazo, Jill Bargonetti. Cancer Res 2020
Times Cited: 12







List of co-cited articles
88 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4.
Alla Polotskaia, Gu Xiao, Katherine Reynoso, Che Martin, Wei-Gang Qiu, Ronald C Hendrickson, Jill Bargonetti. Proc Natl Acad Sci U S A 2015
50
58

Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.
Madhusudhan Kollareddy, Elizabeth Dimitrova, Krishna C Vallabhaneni, Adriano Chan, Thuc Le, Krishna M Chauhan, Zunamys I Carrero, Gopalakrishnan Ramakrishnan, Kounosuke Watabe, Ygal Haupt,[...]. Nat Commun 2015
75
33

Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment.
E M Alexandrova, A R Yallowitz, D Li, S Xu, R Schulz, D A Proia, G Lozano, M Dobbelstein, U M Moll. Nature 2015
198
33

Mutant p53 as a guardian of the cancer cell.
Fiamma Mantovani, Licio Collavin, Giannino Del Sal. Cell Death Differ 2019
223
25

New therapeutic strategies to treat human cancers expressing mutant p53 proteins.
Giovanni Blandino, Silvia Di Agostino. J Exp Clin Cancer Res 2018
98
25

Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZ.
M Escoll, R Gargini, A Cuadrado, I M Anton, F Wandosell. Oncogene 2017
49
25

Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.
Ge Zhou, Jiping Wang, Mei Zhao, Tong-Xin Xie, Noriaki Tanaka, Daisuke Sano, Ameeta A Patel, Alexandra M Ward, Vlad C Sandulache, Samar A Jasser,[...]. Mol Cell 2014
145
25

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
Gene A Lang, Tomoo Iwakuma, Young-Ah Suh, Geng Liu, V Ashutosh Rao, John M Parant, Yasmine A Valentin-Vega, Tamara Terzian, Lisa C Caldwell, Louise C Strong,[...]. Cell 2004
761
25

Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication.
Shilpa Singh, Catherine A Vaughan, Rebecca A Frum, Steven R Grossman, Sumitra Deb, Swati Palit Deb. J Clin Invest 2017
21
25

Mutant p53: one name, many proteins.
William A Freed-Pastor, Carol Prives. Genes Dev 2012
724
25

Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.
Eleonora Ingallina, Giovanni Sorrentino, Rebecca Bertolio, Kamil Lisek, Alessandro Zannini, Luca Azzolin, Luisa Ulloa Severino, Denis Scaini, Miguel Mano, Fiamma Mantovani,[...]. Nat Cell Biol 2018
58
25

Mutant p53 in cancer therapy-the barrier or the path.
Xiang Zhou, Qian Hao, Hua Lu. J Mol Cell Biol 2019
70
25

Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Dun Li, Natalia D Marchenko, Ramona Schulz, Victoria Fischer, Talia Velasco-Hernandez, Flaminia Talos, Ute M Moll. Mol Cancer Res 2011
176
25

ATR/CHK1 inhibitors and cancer therapy.
Zhaojun Qiu, Nancy L Oleinick, Junran Zhang. Radiother Oncol 2018
103
25

The p53 protein is an unusually shaped tetramer that binds directly to DNA.
P N Friedman, X Chen, J Bargonetti, C Prives. Proc Natl Acad Sci U S A 1993
232
25

Identification, validation, and targeting of the mutant p53-PARP-MCM chromatin axis in triple negative breast cancer.
Wei-Gang Qiu, Alla Polotskaia, Gu Xiao, Lia Di, Yuhan Zhao, Wenwei Hu, John Philip, Ronald C Hendrickson, Jill Bargonetti. NPJ Breast Cancer 2017
19
25

p53 gain-of-function mutations increase Cdc7-dependent replication initiation.
Arindam Datta, Dishari Ghatak, Sumit Das, Taraswi Banerjee, Anindita Paul, Ramesh Butti, Mahadeo Gorain, Sangeeta Ghuwalewala, Anirban Roychowdhury, Sk Kayum Alam,[...]. EMBO Rep 2017
18
25

DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.
S K Alam, V K Yadav, S Bajaj, A Datta, S K Dutta, M Bhattacharyya, S Bhattacharya, S Debnath, S Roy, L A Boardman,[...]. Cell Death Differ 2016
48
16

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway.
William A Freed-Pastor, Hideaki Mizuno, Xi Zhao, Anita Langerød, Sung-Hwan Moon, Ruth Rodriguez-Barrueco, Anthony Barsotti, Agustin Chicas, Wencheng Li, Alla Polotskaia,[...]. Cell 2012
541
16

The onset of p53 loss of heterozygosity is differentially induced in various stem cell types and may involve the loss of either allele.
Y Shetzer, S Kagan, G Koifman, R Sarig, I Kogan-Sakin, M Charni, T Kaufman, M Zapatka, A Molchadsky, N Rivlin,[...]. Cell Death Differ 2014
26
16

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.
P Dong, M Karaayvaz, N Jia, M Kaneuchi, J Hamada, H Watari, S Sudo, J Ju, N Sakuragi. Oncogene 2013
225
16

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis.
Masatsugu Hiraki, So-Young Hwang, Shugeng Cao, Timothy R Ramadhar, Sanguine Byun, Kyoung Wan Yoon, Jung Hyun Lee, Kiki Chu, Aditi U Gurkar, Vihren Kolev,[...]. Chem Biol 2015
41
16

AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.
Xiangbing Meng, Jianling Bi, Yujun Li, Shujie Yang, Yuping Zhang, Mary Li, Haitao Liu, Yiyang Li, Megan E Mcdonald, Kristina W Thiel,[...]. Cancers (Basel) 2018
28
16

Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers.
Hilla Solomon, Nathan Dinowitz, Ioannis S Pateras, Tomer Cooks, Yoav Shetzer, Alina Molchadsky, Meital Charni, Stav Rabani, Gabriela Koifman, Ohad Tarcic,[...]. Oncogene 2018
43
16


Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.
Silvia Di Agostino, Sabrina Strano, Velia Emiliozzi, Valentina Zerbini, Marcella Mottolese, Ada Sacchi, Giovanni Blandino, Giulia Piaggio. Cancer Cell 2006
310
16

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.
Fabio Valenti, Federica Ganci, Giulia Fontemaggi, Andrea Sacconi, Sabrina Strano, Giovanni Blandino, Silvia Di Agostino. Oncotarget 2015
33
16

Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.
Luiz F Zerbini, Yihong Wang, Ricardo G Correa, Je-Yoel Cho, Towia A Libermann. Cell Cycle 2005
41
16

Mutant p53 in cancer: new functions and therapeutic opportunities.
Patricia A J Muller, Karen H Vousden. Cancer Cell 2014
871
16

p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.
Hoseok Song, Monica Hollstein, Yang Xu. Nat Cell Biol 2007
306
16

Mutant p53 drives invasion by promoting integrin recycling.
Patricia A J Muller, Patrick T Caswell, Brendan Doyle, Marcin P Iwanicki, Ee H Tan, Saadia Karim, Natalia Lukashchuk, David A Gillespie, Robert L Ludwig, Pauline Gosselin,[...]. Cell 2009
563
16


A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian Carcinomas.
Alice Soragni, Deanna M Janzen, Lisa M Johnson, Anne G Lindgren, Anh Thai-Quynh Nguyen, Ekaterina Tiourin, Angela B Soriaga, Jing Lu, Lin Jiang, Kym F Faull,[...]. Cancer Cell 2016
164
16

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
C J Di Como, C Gaiddon, C Prives. Mol Cell Biol 1999
368
16

Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.
Dawid Walerych, Kamil Lisek, Roberta Sommaggio, Silvano Piazza, Yari Ciani, Emiliano Dalla, Katarzyna Rajkowska, Katarzyna Gaweda-Walerych, Eleonora Ingallina, Claudia Tonelli,[...]. Nat Cell Biol 2016
134
16


Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.
Yoav Shetzer, Alina Molchadsky, Varda Rotter. Cold Spring Harb Perspect Med 2016
30
16

Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion.
P A J Muller, A G Trinidad, P Timpson, J P Morton, S Zanivan, P V E van den Berghe, C Nixon, S A Karim, P T Caswell, J E Noll,[...]. Oncogene 2013
137
16

Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy.
Xuetian Yue, Yuhan Zhao, Yang Xu, Min Zheng, Zhaohui Feng, Wenwei Hu. J Mol Biol 2017
131
16

Pla2g16 phospholipase mediates gain-of-function activities of mutant p53.
Shunbin Xiong, Huolin Tu, Madhusudhan Kollareddy, Vinod Pant, Qin Li, Yun Zhang, James G Jackson, Young-Ah Suh, Ana C Elizondo-Fraire, Peirong Yang,[...]. Proc Natl Acad Sci U S A 2014
58
16

Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth.
Jiajun Zhu, Morgan A Sammons, Greg Donahue, Zhixun Dou, Masoud Vedadi, Matthäus Getlik, Dalia Barsyte-Lovejoy, Rima Al-awar, Bryson W Katona, Ali Shilatifard,[...]. Nature 2015
263
16

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.
Sunil R Hingorani, Lifu Wang, Asha S Multani, Chelsea Combs, Therese B Deramaudt, Ralph H Hruban, Anil K Rustgi, Sandy Chang, David A Tuveson. Cancer Cell 2005
16

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.
K V Chin, K Ueda, I Pastan, M M Gottesman. Science 1992
807
16

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
Tamara Terzian, Young-Ah Suh, Tomoo Iwakuma, Sean M Post, Manja Neumann, Gene A Lang, Carolyn S Van Pelt, Guillermina Lozano. Genes Dev 2008
259
16

Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization.
Y Peng, L Chen, C Li, W Lu, J Chen. J Biol Chem 2001
122
16

Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.
Marco Cordani, Elisa Oppici, Ilaria Dando, Elena Butturini, Elisa Dalla Pozza, Mercedes Nadal-Serrano, Jordi Oliver, Pilar Roca, Sofia Mariotto, Barbara Cellini,[...]. Mol Oncol 2016
69
16


Geldanamycin selectively destabilizes and conformationally alters mutated p53.
M V Blagosklonny, J Toretsky, L Neckers. Oncogene 1995
168
16

Stathmin regulates mutant p53 stability and transcriptional activity in ovarian cancer.
Maura Sonego, Monica Schiappacassi, Sara Lovisa, Alessandra Dall'Acqua, Marina Bagnoli, Francesca Lovat, Massimo Libra, Sara D'Andrea, Vincenzo Canzonieri, Loredana Militello,[...]. EMBO Mol Med 2013
40
16

Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells.
S Masciarelli, G Fontemaggi, S Di Agostino, S Donzelli, E Carcarino, S Strano, G Blandino. Oncogene 2014
93
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.